Loading…
Outlook Therapeutics, Inc. is projected to rise to $1.43 by 2027, a +46% move from its current price of $0.9766. OTLK is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $0.896 | $0.9779 | $1.07 | +0.13% |
| Aug 5 | $0.8653 | $0.9792 | $1.11 | +0.27% |
| Aug 6 | $0.8428 | $0.9806 | $1.14 | +0.41% |
| Aug 7 | $0.8243 | $0.9819 | $1.17 | +0.54% |
| Aug 8 | $0.8086 | $0.9832 | $1.20 | +0.68% |
| Aug 9 | $0.7947 | $0.9845 | $1.22 | +0.81% |
| Aug 10 | $0.7822 | $0.9859 | $1.24 | +0.95% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.7822 | $0.9859 | $1.24 | +0.95% |
| Week 2 | $0.7175 | $0.9952 | $1.38 | +1.91% |
| Week 3 | $0.673 | $1.00 | $1.50 | +2.87% |
| Week 4 | $0.6385 | $1.01 | $1.61 | +3.85% |
| Week 5 | $0.6103 | $1.02 | $1.72 | +4.83% |
| Week 6 | $0.5864 | $1.03 | $1.82 | +5.83% |
| Week 7 | $0.5657 | $1.04 | $1.92 | +6.83% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Outlook Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focusing on monoclonal antibodies for ophthalmic indications.
Its lead product candidate is ONS-5010, an ophthalmic bevacizumab formulation that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases.
Outlook Therapeutics has collaboration agreements with Cencora. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. It was incorporated in 2010 and is based in Iselin, New Jersey.
Outlook Therapeutics, Inc. (OTLK) currently trades at $1.00 and has a market capitalization of $187M.
In the market ranking, it sits at position 3832. The near-term outlook shows a path of rising valuation in the longer horizon, with the annualized forecast indicating a bullish trajectory after a neutral start in 2026.
Forecasts show a progression from a 2026 average of $1.00 to considerably higher levels by later years, with 2030 averaging $2.03 and 2050 averaging $22.05, implying meaningful upside potential over the long term.
A major floor 79.7% below — a decisive break under it would weaken the trend.
The nearest floor, 7.4% below — buyers have tended to step in here.
The nearest ceiling, 87.4% above — a clean break opens room to run.
A major ceiling 121.5% above — clearing it would confirm fresh momentum.
Key OTLK support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OTLK market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.9972 | Sell | $1.05 | Sell |
| MA 10 | $1.19 | Sell | $1.16 | Sell |
| MA 20 | $1.37 | Sell | $1.26 | Sell |
| MA 50 | $1.20 | Sell | $1.16 | Sell |
| MA 100 | $0.7376 | Buy | $0.9883 | Sell |
| MA 200 | $0.9346 | Buy | $1.09 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.29 | Neutral |
| Stoch RSI (14) | 13.83 | Buy |
| CCI (20) | -135.05 | Sell |
| Williams %R (14) | -91.16 | Info |
| MACD (12,26,9) | -0.08 | Sell |
| ROC (12) | -37.37 | Sell |
| Bollinger %B (20,2) | 0.10 | Neutral |
| Stochastic %K (14) | 8.84 | Buy |
| TRIX (15) | 0.03 | Buy |
| Awesome (5,34) | -0.45 | Sell |
| Ultimate (7,14,28) | 29.03 | Buy |
| Momentum (10) | -0.41 | Sell |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 0.89 | Buy |
| ADX (14) | 22.97 | Sell |
| ATR (14) | 0.10 | Info |
The near-term technical picture is described as BULLISH overall. The RSI14 is 40, with the 50-day simple moving average at $1.17 and the 200-day simple moving average at $0.937.
Key support and resistance levels are $0.904 and $1.83 respectively, framing the immediate trading area. The 30-day range spans from $0.5465 up to $1.83, highlighting a broad short-term trading window and ongoing volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.198 | $0.9766 | $1.57 | 0% | Neutral | |
| $1.04 | $1.43 | $2.12 | +46% | Bullish | |
| $1.19 | $1.74 | $2.75 | +78% | Bullish | |
| $1.40 | $2.16 | $3.59 | +121% | Bullish | |
| $1.22 | $1.96 | $3.40 | +101% | Bullish | |
| $1.34 | $2.26 | $4.06 | +132% | Bullish | |
| $1.74 | $3.07 | $5.67 | +214% | Bullish | |
| $2.14 | $3.93 | $7.47 | +302% | Bullish | |
| $2.83 | $5.40 | $10.52 | +453% | Bullish | |
| $2.79 | $5.52 | $11.01 | +465% | Bullish | |
| $4.55 | $10.11 | $22.18 | +936% | Bullish | |
| $9.72 | $21.60 | $49.67 | +21.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.198 | $0.9766 | $1.32 | +0.00% |
| September 2026 | $0.8795 | $1.07 | $1.36 | +9.58% |
| October 2026 | $0.8953 | $1.10 | $1.43 | +3.20% |
| November 2026 | $0.9485 | $1.18 | $1.56 | +7.15% |
| December 2026 | $0.9333 | $1.18 | $1.57 | -0.58% |
Click any year to see its month-by-month OTLK forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, OTLK could reach as high as $1.57, with a base case around $0.9766 and support toward $0.198 — roughly 0% from $0.9766. A consolidation phase looks the most probable path here.
Expect OTLK to range from $1.04 to $2.12 through 2027. The $1.43 average target implies a +46% move from current prices. That is up +46% on the projected 2026 average. Momentum favours further upside here.
The OTLK price prediction for 2028 points to an average of $1.74 (low $1.19, high $2.75) — a potential gain of +78% on today's $0.9766. Buyers look set to stay in control over this stretch.
In 2029, OTLK is projected to trade between $1.40 and $3.59, averaging $2.16 — a potential gain of +121% from today's $0.9766. That is up +24% on the projected 2028 average. Momentum favours further upside here.
Outlook Therapeutics, Inc.'s 2030 outlook centres on $1.96, within a $1.22 to $3.40 range. That is -9% versus the projected 2029 average. That marks a +101% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, OTLK could reach as high as $4.06, with a base case around $2.26 and support toward $1.34 — roughly +132% from $0.9766. Momentum favours further upside here.
Expect OTLK to range from $1.74 to $5.67 through 2032. The $3.07 average target implies a +214% move from current prices. That is up +36% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The OTLK price prediction for 2033 points to an average of $3.93 (low $2.14, high $7.47) — a potential gain of +302% on today's $0.9766. Momentum favours further upside here.
In 2034, OTLK is projected to trade between $2.83 and $10.52, averaging $5.40 — a potential gain of +453% from today's $0.9766. That is up +37% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Outlook Therapeutics, Inc.'s 2035 outlook centres on $5.52, within a $2.79 to $11.01 range. That is up +2% on the projected 2034 average. That marks a +465% change versus current levels. Momentum favours further upside here.
By 2040, OTLK could reach as high as $22.18, with a base case around $10.11 and support toward $4.55 — roughly +936% from $0.9766. Buyers look set to stay in control over this stretch.
Expect OTLK to range from $9.72 to $49.67 through 2050. The $21.60 average target implies a +21.1x move from current prices. That is up +114% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in OTLK today (≈ 1,023.96068 OTLK) could be worth
$22,113.89
+$21,113.89 (+2111%) by 2050 · US Dollar
Based on the average projected OTLK price of $21.6 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OTLKwould be worth at today's price.
$1,000 invested in OTLK on Jul 31, 2025 (≈ 510.204072 OTLK) would be worth
$498.27
-$501.73 (-50.2%) today · 0.50× · US Dollar
Based on a OTLK entry price of $1.96 vs. today's $0.9766.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.4 | $695.09 | -30.5% |
| 1 month ago | $1.47 | $664.35 | -33.6% |
| 3 months ago | $0.262 | $3,727.48 | +272.7% |
| 6 months ago | $0.44 | $2,219.55 | +122.0% |
| 1 year ago | $1.96 | $498.27 | -50.2% |
| All time (5.0y) ago | $44 | $22.2 | -97.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OTLK forecast.
Our base-case forecast reaches $2.00 around 2029.
Implied market cap at $2.00: $373.99M
The multi-year forecast shows bullish sentiment across multiple years, with notable milestones in the averages and ROI. For 2030, the average forecast is $2.03 with a max of $3.51 and a min of $1.26, yielding an ROI of 102.8%. For 2040, the average is $10.45 with a max of $22.93 and ROI of 945.4%.
By 2050, the average forecast reaches $22.05 with a max of $50.72 and ROI of 2105.4%.
The 2026 forecast is neutral with an average of $1.00, but the outlook turns bullish in 2027 through 2050 as averages rise and upside potential expands. These figures are estimates and not guarantees, and they reflect the potential trajectory of the asset under the stated assumptions.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $2.03 with a range from $1.26 to $3.51 and a projected ROI of 102.8%, with a bullish sentiment.
Forecasts indicate bullish sentiment from 2027 onward with rising averages, including a 2050 average of $22.05 and ROI of 2105.4%. The 2026 forecast is neutral, and these figures are estimates, not guarantees.
Yes. The forecast shows 2033 with an average of $4.05 and 2034 with a max of $10.85, indicating that $5 is within the forecast range in the mid-2030s.
Current price: $1.00. Market cap: $187M. The rank is 3832.
RSI14 is 40. SMA50 is $1.17 and SMA200 is $0.937. Support is at $0.904 and resistance at $1.83. The 30-day range is $0.5465 to $1.83, with bullish overall sentiment.
Outlook Therapeutics, Inc. Community Discussion
0Share your Outlook Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.